Relafen Naproxium 750, viewed or considered from a biochemical molecular pharmacy perspective, represents a compelling vital illustration of NSAID or non-copyrightal anti-inflammatory drug action. Its mechanism process involves primarily substantially inhibiting cyclooxygenase enzymes, specifically COX-2, thereby reducing lowering the production of